The business model of Gimv NV is focused on equity investment and venture capital. As a leading European investment company, Gimv NV aims to support ambitious entrepreneurs and companies at various stages of their development. They provide patient capital, expertise, and a network of contacts to help businesses grow and succeed. With a long-term growth perspective, Gimv NV actively invests in a diversified portfolio of companies across different sectors, including Health & Care, Smart Industries, Sustainable Cities, and Consumer 2025. By fostering innovation, entrepreneurship, and sustainable growth, Gimv NV strives to create value for both its portfolio companies and shareholders.

Gimv NV is primarily active in various industries such as biotechnology, healthcare, technology, and consumer goods.

The main competitors of Gimv NV in the market are other private equity firms and investment companies. They compete with companies such as KKR & Co. Inc., The Carlyle Group, and Apax Partners. These competitors also focus on providing investment and financing solutions to businesses across various industries. However, Gimv NV differentiates itself through its sector expertise and long-term partnerships with companies, offering added value and insights to their portfolio.

Gimv NV is a renowned Belgian investment company with a rich history and extensive background. Founded in 1980, Gimv has been actively involved in fostering promising businesses across various sectors. It initially focused on providing capital to local startups and small businesses, gradually expanding its reach internationally. Over the years, Gimv has evolved to become a leading player in private equity and venture capital investments. With a strong portfolio of companies spanning technology, healthcare, consumer goods, and more, Gimv has helped numerous firms achieve their growth objectives. Guided by a talented team and a forward-thinking approach, Gimv continues to generate value for its shareholders and contribute to economic development.

Gimv NV, a leading investment company, has accomplished several significant milestones throughout its history. Notably, it has successfully invested in numerous high-potential businesses, driving their growth and profitability. Gimv NV has also established a strong track record of strategic acquisitions and divestments, enhancing its portfolio and generating excellent returns for shareholders. The company's expertise spans various sectors, including technology, healthcare, and sustainable investments. By consistently identifying and partnering with innovative companies, Gimv NV has solidified its position as a trusted investor in the market. Its dedication to fostering long-term value and sustainable growth has made it a prominent player in the industry.

Gimv NV is primarily present in Belgium, the Netherlands, France, and Germany.

Gimv NV is a company that embodies values of trust, innovation, and sustainability. With a strong corporate philosophy, Gimv NV strives to create long-term value for its stakeholders by investing in promising companies and helping them reach their full potential. The company focuses on sectors such as Health & Care, Smart Industries, and Sustainable Cities. By leveraging its expertise and network, Gimv NV actively supports its portfolio companies in their growth journey. With its commitment to responsible entrepreneurship, Gimv NV aims to make a positive impact on society and the environment.

Analysts currently set an average price target of 51.00 EUR for the Gimv stock (median: 53.04 EUR), implying +14.2 % versus the latest price. The consensus is based on 9 analyst ratings.

Gimv Analyst Price Targets 2026

9 analysts currently rate the Gimv stock: 7 recommend buying, 2 holding and 0 selling.

Gimv Analyst Price Targets 2026

The Gimv share (GIMB.BR) is listed on 5 stock exchanges, including: Frankfurt (GI3.F), München (GI3.MU), London (0EKR.L).

Gimv NV is a private equity company based in Belgium that invests in companies in various industries and regions. The company follows a buy-and-build strategy, acquiring companies with growth potential and then scaling them globally. Gimv has six focus areas: Consumer, Health & Care, Technology, Cleantech, Sustainable Cities, and Smart Industries.

The revenue of Gimv is 86.94 M EUR. This figure is based on current financial data and reflects the company's business performance.

The profit of Gimv is 173.31 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Gimv is currently 9.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Gimv stock.

The price-to-sales ratio (P/S) of Gimv is currently 18.37. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Gimv stock.

The Eulerpool Quality Score for Gimv is 3/10.

The ISIN of Gimv is BE0003699130. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Gimv is 907547. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Gimv is GIMB.BR. The ticker symbol is used to trade Gimv shares on the stock exchange.

Over the past 12 months, Gimv paid a dividend of 2.60 EUR . This corresponds to a dividend yield of about 5.92 %. For the coming 12 months, Gimv is expected to pay a dividend of 2.60 EUR.

The current dividend yield of Gimv is 5.92 %.

Gimv pays a dividend, distributed in the months of , , , .

Gimv paid dividends every year for the past 22 years.

For the upcoming 12 months, dividends amounting to 2.60 EUR are expected. This corresponds to a dividend yield of 5.87 %.

Gimv is assigned to the 'Finance' sector.

To receive the latest dividend of Gimv from amounting to 2.6 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Gimv distributed 2.52 EUR as dividends.

The dividends of Gimv are distributed in EUR.